CELLECTAR LLC has a total of 27 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are ALKALIDX INC, CREIGHTON UNIV and MIVENION GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 3 | |
#3 | Republic of Korea | 3 | |
#4 | Mexico | 3 | |
#5 | Brazil | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Israel | 2 | |
#9 | United States | 2 | |
#10 | South Africa | 2 | |
#11 | Australia | 1 | |
#12 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Longino Marc | 13 |
#2 | Pinchuk Anatoly | 12 |
#3 | Weichert Jamey | 12 |
#4 | Weichert Jamey P | 10 |
#5 | Longino Marc A | 7 |
#6 | Marc Longino | 3 |
#7 | Anatoly Pinchuk | 2 |
#8 | Jamey Weichert | 2 |
#9 | Muehler Andreas | 2 |
#10 | Longino Mark A | 1 |
Publication | Filing date | Title |
---|---|---|
MX2007007497A | Phospholipid ether analogs for detecting and treating cancer. | |
AU2005269861A1 | Virtual colonoscopy with radiolabeled phospholipid ether analogs | |
WO2005084716A2 | Phospholipid analogs for diagnosis and treatment of cancer |